Delivery Order SPE2DR25D9901-SPE2DR26FMKB6
Award Date 3/9/26
Potential Completion Date 3/10/26
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division issued a $1,854.80 delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, for diazepam injection. The order was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place...
- The Defense Logistics Agency issued a $17,866.52 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense healthcare operations. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499,999,999 ceiling and a December 31, 2036 ultimate completion date. DMS Pharmaceutical Group is a woman-owned small business...
- The Defense Logistics Agency issued a $1,919.48 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, specialty pharmaceuticals,...
- The Defense Logistics Agency issued a $1,737.68 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency program that authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and...
- The Defense Logistics Agency issued a $4,422.16 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a ceiling of $499.999 billion authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a $99,504.78 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 25, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and...
- The Defense Logistics Agency issued a $11,591.04 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and...
- The Defense Logistics Agency issued a $24,132.70 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499.9 million ceiling and an ultimate completion date of December 31, 2036. The program authorizes firm fixed-price delivery orders for branded...
- The Defense Logistics Agency issued a $1,525.41 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 22, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics,...
- The Defense Logistics Agency issued a $19,508.70 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on March 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. The order carries a firm fixed...